NovoCure Limited - Ordinary Shares (NVCR): Price and Financial Metrics
NovoCure Limited - Ordinary Shares (NVCR)
Today's Latest Price: $61.20 USD
1.66 (-2.64%)
Updated Jul 7 1:45pm
Add NVCR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NVCR Stock Summary
- NVCR's current price/earnings ratio is 711.64, which is higher than 99.34% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for NVCR is currently 191.95, higher than 98.31% of US stocks with positive operating cash flow.
- With a price/sales ratio of 16.62, NovoCure Ltd has a higher such ratio than 91.58% of stocks in our set.
- Stocks that are quantitatively similar to NVCR, based on their financial statements, market capitalization, and price volatility, are CEVA, ATRS, EGRX, INTT, and ANGI.
- To check out NovoCure Ltd's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001645113.
NVCR Daily Price Range
NVCR 52-Week Price Range
NVCR Stock Price Chart Technical Analysis Charts
NVCR Price/Volume Stats
| Current price | $61.20 | 52-week high | $98.84 |
| Prev. close | $62.86 | 52-week low | $53.40 |
| Day low | $60.99 | Volume | 312,405 |
| Day high | $62.73 | Avg. volume | 1,027,257 |
| 50-day MA | $64.16 | Dividend yield | N/A |
| 200-day MA | $74.97 | Market Cap | 6.15B |
NovoCure Limited - Ordinary Shares (NVCR) Company Bio
NovoCure Limited is a commercial stage oncology company which develops treatment for solid tumor cancers therapy called the tumor treating fields. The company was founded in 2000 and is based in Saint Helier, Channel Islands.
Loading social stream, please wait...